Brief: Telo Genomics Announces Multiple Myeloma Collaboration With Mayo Clinic
20/12/2019 14:07
Dec 20 (Reuters) - Telo Genomics Corp TELO.V :
* TELO GENOMICS ANNOUNCES MULTIPLE MYELOMA COLLABORATION
WITH MAYO
CLINIC
* TELO GENOMICS CORP - PHASE 1 OF STUDIES IS EXPECTED TO BE
LAUNCHED WITHIN Q1 OF 2020
Source text for Eikon: ID:nGNX3BL2qn
Further company coverage: TELO.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Telo Genomics
See all newsBrief: Telo Genomics Announces Positive Results Of Smoldering Multiple Myeloma Proof Of Concept Study
Brief: Telo Genomics Announces Final Assignment Of Patents On Hematological Cancers, Liquid Biopsy & Alzheimer's Disease
Brief: Telo Genomics Announces Multiple Myeloma Collaboration With Mayo Clinic
Brief: 3D Signatures Announces Name Change To Telo Genomics Corp
Brief: 3D Signatures Says Current Board And Executive Management Team Do Not Intend To File For Bankruptcy